Jeffrey R. Strawn, MD

Optimizing benzodiazepine treatment of anxiety disorders

Understanding the pharmacology of these agents can help guide medication selection and dosing.

Author:: Sarah Hamill Skoch, PhD; Julia N. Stimpfl, MD; Jeffrey R. Strawn, MD

Behavioral interventions should be implemented before considering pharmacotherapy

Author:: Sarah Hamill Skoch, PhD; Julia N. Stimpfl, MD; Jeffrey R. Strawn, MD

Sleep problems are common among children and adolescents,¹ with prevalence rates of 25% to 40%.^2-4 Young children m...

As we talk with children, we must remember that they may be implicitly asking for more than a number, date, or mechanism.

Jeffrey R. Strawn, MD, discusses antidepressants and other treatments for a pediatric patient with an anxiety disorder.

Stimulants are first-line psychopharmacologic interventions for attention-deficit/hyperactivity disorder (ADHD), and their efficacy is supported...

One fine winter’s day when Piglet was brushing away the snow in front of his house he happened to look up, and there was Winnie-the-Pooh. Pooh was...

Author:: Jennifer O'Malley, MD, PhD; Edward J. Richer, MD; Jeffrey R. Strawn, MD

The first 15 years of the new millennium have seen a great increase in research on neuroimaging in children and adolescents who have a psychiatric...

Jeffrey R. Strawn, MD, discusses how to proceed when an adolescent isn’t responding adequately to an antidepressant.

Jeffrey R. Strawn, MD, talks about predictors of outcome and multimodal treatment for anxiety disorders in children

Research supports SSRIs, other medications as part of a multimodal approach

Empiric evidence clarifies risk factors, causes, and first-line interventions.